
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+3
Summit Biosciences Inc. has been acquired by Kindeva Drug Delivery, a global force in drug-device combination product development and manufacturing with expertise across pulmonary & nasal, injectable, and transdermal delivery. Summit brings its innovative nasal spray drug product capabilities to Kindeva, with the capacity to support any stage of product development, from conceptual to commercial, as well as our cGMP facility in Lexington, KY. Under Kindevas leadership, our dedicated and talented workforce will continue to drive our vision of increasing the availability of nasal drug-delivery options. For the most up-to-date information and news, please follow Kindevas page: https://www.linkedin.com/company/kindeva-drug-delivery/. To explore...
Nasal spray drug product development,nasal spray drug product manufacturing,ich stability monitoring,cmc regulatory strategy,in-vitro bioequivalence studies,formulation development,method development & validation,and drug delivery systems development
Formerly summit biosciences inc. | kdd operates in the Pharmaceutical manufacturing industry.
Formerly summit biosciences inc. | kdd's revenue is 11m - 100m
Formerly summit biosciences inc. | kdd has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.